Maine 2023-2024 Regular Session

Maine Senate Bill LD1728

Introduced
4/20/23  
Refer
4/20/23  
Engrossed
5/25/23  
Enrolled
5/30/23  

Caption

An Act to Ensure Access to Federally Approved Opioid Overdose-reversing Medication

Companion Bills

No companion bills found.

Similar Bills

ME LD710

An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications

CA AB1037

Public health: substance use disorder.

AZ SB1211

Pharmacists; prescribing; naloxone; reporting

CA AB915

Pupil health: drug education: opioid overdose training program.

NJ S3287

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

NJ A4244

Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and resident assistants.

NJ S899

Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and designated persons.

NJ S2803

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.